University of Ioannina
Σύνθεση, χαρακτηρισμός και μελέτη της βιολογικής δραστικότητας πολυπυρηνικών οργανομεταλλικών συμπλόκων του ρουθηνίου
Abstract
dc:descriptionChemotherapy is largely based on the interaction of molecules with DNA, inhibiting cell proliferation. The binding of these compounds to DNA can be covalent or non-covalent. Many complex compounds have been applied in this context, with the most notable example being cisplatin, which was the first approvedmetal-based anticancer drug back in 1974. Cisplatin’s binding to DNA takes place covalently, after the hydrolysis of the complex and the formation of an adduct with N7 of guanine, resulting in cell apoptosis. Despite its widespread use, and that of its derivatives, cisplatin does not target cancer cells, causing serious side effects. In addition, a large percentage of patients who are given cisplatin develop drug-resistance, resulting in reduced effectiveness. Therefore, there is a need for new chemotherapeutic agents, possibly with a different mode of action in order to overcome these issues. An alternative to complexes that bind covalently to DNA are those that act non-covalently. The two main ways of non-covalent binding with DNAare intercalation, which includes the insertion of a molecule between two adjacent DNA bases, and groovebinding. These interactions result in a change of the structure of the DNA double helix and, consequently,cell apoptosis, a process that is beneficial in the fight against cancer. The first non-covalent DNA binderswere organic molecules, but inorganic complexes have also attracted significant interest, as they offer important advantages, such as the fact that the metal center holds the ligands, that are the ones bindingwith DNA, in possibly favorable positions. In this context, Ru(II) complexes have attracted considerable interest. In addition, it has been shown that small molecules’ ability to bind to DNA can be significantly improved by introducing a second functional unit capable of interacting with DNA, thus leading to increased cytotoxicity. Based on the above, new dinuclear and mononuclear Ru(II)-arene complexes with oligopyridine ligands and saturated coordination sphere were synthesized and characterized with the following general formulas:{[Ru(cym)(L1)]2(μ-BLi)}2+, {[Ru2(cym)2(L1)(L2)](μ-BLi)}3+, {[Ru(cym)(L1)]2(μ-BLi)}4+ and [Ru(cym)(L1)(BLi)]2+(cym = p-cymene, L1 or L2 = ppy-H+ or bzq-H+ or phen (Image Ι) and BLi = BL1 - BL5 (Image Ι)). The chelatin gligands determine the overall charge of the complex. 2D NMR (NOESY) was used to study the structural characteristics of the complexes. Furthermore, for {[Ru(cym)(bzq-H+)]2(μ-BLi)}(PF6)2 (where BLi = BL1, BL2,BL3), suitable crystals for X-ray crystallography were isolated and studied. The above complexes interactions with B type oligonucleotides d(5′-CGCGCG-3′)2, d(5′-CTTTTGCAAAAG3′)2 and d(5′-CGCGAATTCGCG-3′)2, as well as with Calf Thymus DNA (CT DNA), were studied the nuclearmagnetic resonance spectroscopy (NMR) and through fluorescence quenching experiments with ethidiumbromide (EB). Using these techniques, it was possible to draw conclusions about the complexes’ binding strength towards DNA, and also to correlate this with the total charge and also with the rigidity and the length of the BL. All complexes were found to bind non-covalently with DNA, through a mix of bindingmodes, such as intercalation, grove binding, electrostatic interactions. The Stern-Volmer constant (KSV) and binding constant (Kb) were also calculated. Finally, cytotoxic assessment studies were also conducted, against the cell lines MCF-7, A2780 and A2780cis-res, from which the IC50 values were calculated. These studies proved a moderate selectivity for cancer cells for the studied complexes.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Thomos, Dimitrios
- Θώμος, Δημήτριος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61682